HCV 3a Core Protein Increases Lipid Droplet Cholesteryl Ester Content via a Mechanism Dependent on Sphingolipid Biosynthesis-Reference-Cited by-同舟云学术

HCV 3a Core Protein Increases Lipid Droplet Cholesteryl Ester Content via a Mechanism Dependent on Sphingolipid Biosynthesis

Published:2014-12-18 Issue:12 Volume:9 Page:e115309
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Loizides-Mangold Ursula,Clément Sophie,Alfonso-Garcia Alba,Branche Emilie,Conzelmann Stéphanie,Parisot Clotilde,Potma Eric O.,Riezman Howard,Negro Francesco

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference61 articles.

1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST (2013) Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence, Hepatology. 57 : p. 1333–42.

2. Grebely J, Dore GJ (2011) What is killing people with hepatitis C virus infection? Semin Liver Dis. 31 : p. 331–9.

3. Machado MV, Oliveira AG, Cortez-Pinto H (2011) Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients, J Gastroenterol Hepatol. 26 : p. 1361–7.

4. Rubbia-Brandt L, Quadri R, Abid K, Giostra E, Male PJ, et al.. (2000) Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3, J Hepatol. 33 : p. 106–15.

5. Abid K, Pazienza V, de Gottardi A, Rubbia-Brandt L, Conne B, et al.. (2005) An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation, J Hepatol. 42 : p. 744–51.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of Lipid Droplet Accumulation in Steatotic Liver Diseases;Seminars in Liver Disease;2023-10-05

2. The interplay between lipid droplets and virus infection;Journal of Medical Virology;2023-07

3. Interplay between lipid metabolism, lipid droplets and RNA virus replication;Critical Reviews in Microbiology;2023-06-22

4. The role of serum sphingolipids as potential biomarkers of non‐response to direct acting antiviral therapy in chronic hepatitis C virus infection;Journal of Viral Hepatitis;2022-12-13

5. What role for cellular metabolism in the control of hepatitis viruses?;Frontiers in Immunology;2022-11-17